Jiewei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jiewei Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Li Hua Jin
College of Life Sciences, Northeast Forestry University, Harbin, China
3 shared publications Ping Wang
College of Life Sciences, Northeast Forestry University, Harbin, China
3 shared publicationsJiangong Zhang
College of Life Sciences, Northeast Forestry University, Harbin, China
2 shared publicationsXinran Li
College of Life Sciences, Northeast Forestry University, Harbin, China
2 shared publicationsWendong Liu
College of Life Sciences, Northeast Forestry University, Harbin, China
1 shared publicationXianhao Li
College of Life Sciences, Northeast Forestry University, Harbin, China
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (11) , 103117
Microbiota-derived SCFAs modulate Socs36E-mediated feedback to regulate intestinal stem cell proliferation upon Atg4 loss in Drosophila
- 15 October 2026
- Published by Elsevier in Stem Cell Reports
- Vol. 21 (11) , 103117
Open AccessMicrobiota-derived SCFAs modulate Socs36E-mediated feedback to regulate intestinal stem cell proliferation upon Atg4 loss in Drosophila
- Open Access
- 31 August 2026
- Published by Springer Nature in Microbiome
- Vol. 14 (1) , 208
Correction: Atg2 coordinates microbial metabolite signaling and epigenetic remodeling to maintain intestinal lipid homeostasis in Drosophila
- 31 August 2026
- Published by Springer Nature in Microbiome
- Vol. 14 (1) , 208
Open AccessCorrection: Atg2 coordinates microbial metabolite signaling and epigenetic remodeling to maintain intestinal lipid homeostasis in Drosophila
- Open Access
- 27 March 2026
- Published by Springer Nature in Microbiome
- Vol. 14 (1)
Atg2 coordinates microbial metabolite signaling and epigenetic remodeling to maintain intestinal lipid homeostasis in Drosophila
Background: The autophagy-related protein Atg2 maintains intestinal homeostasis by preventing lipid accumulation and microbial dysbiosis; however, the mechanisms by which these pathologies interconnect remain unknown. Results: We identify a microbiota‒metabolite‒epigenome axis through which Atg2 deficiency triggers metabolic‒immune cascades in the Drosophila intestine. Tissue-specific Atg2 depletion disrupts autophagic flux, provoking commensal overgrowth and pathogenic overproduction of short-chain fatty acids (SCFAs). Elevated SCFAs drive acetyl-CoA overflow, inducing global protein hyperacetylation that simultaneously activates lipogenic programs and primes innate immunity. Crucially, microbiota ablation or SCFAs restriction fully reverses lipid–immune dysregulation, mechanistically linking microbial metabolites to host pathophysiology. Conclusions: Our work establishes Atg2 as a guardian of microbiota-derived metabolite signaling, demonstrating that autophagy constrains microbial byproducts to prevent acetyl-CoA-mediated epigenetic hijacking of metabolic and immune networks. These findings reveal protein acetylation as a convergent regulator linking commensal ecology to host physiology, suggesting metabolite-centric therapies for dysbiosis-associated disorders.
- 27 March 2026
- Published by Springer Nature in Microbiome
- Vol. 14 (1)
Open AccessAtg2 coordinates microbial metabolite signaling and epigenetic remodeling to maintain intestinal lipid homeostasis in Drosophila
Background: The autophagy-related protein Atg2 maintains intestinal homeostasis by preventing lipid accumulation and microbial dysbiosis; however, the mechanisms by which these pathologies interconnect remain unknown. Results: We identify a microbiota‒metabolite‒epigenome axis through which Atg2 deficiency triggers metabolic‒immune cascades in the Drosophila intestine. Tissue-specific Atg2 depletion disrupts autophagic flux, provoking commensal overgrowth and pathogenic overproduction of short-chain fatty acids (SCFAs). Elevated SCFAs drive acetyl-CoA overflow, inducing global protein hyperacetylation that simultaneously activates lipogenic programs and primes innate immunity. Crucially, microbiota ablation or SCFAs restriction fully reverses lipid–immune dysregulation, mechanistically linking microbial metabolites to host pathophysiology. Conclusions: Our work establishes Atg2 as a guardian of microbiota-derived metabolite signaling, demonstrating that autophagy constrains microbial byproducts to prevent acetyl-CoA-mediated epigenetic hijacking of metabolic and immune networks. These findings reveal protein acetylation as a convergent regulator linking commensal ecology to host physiology, suggesting metabolite-centric therapies for dysbiosis-associated disorders.